Elicio Therapeutics Debt to Equity

Elicio Therapeutics posts a debt-to-equity ratio of 0.58. That is above the sector sector average of 0.2. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a debt-to-equity ratio near 0.2 is typical. Elicio Therapeutics's 0.58 is higher that level. That is roughly 189.5% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Elicio Therapeutics's debt-to-equity ratio of 0.58 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for ELTX's debt-to-equity ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 0.2), and (3) consistency with growth and profitability. This page covers the first two; Elicio Therapeutics's other metric pages and overview cover the third.